Solubility Enhancement of Water Insoluble Drug for Ophthalmic Formulation

Authors

  • Sunisha Kulkarni Sri Ram College of pharmacy, Banmore, Morena (M.P.)-INDIA
  • Surya Prakash Gupta Rajiv Gandhi Institute of Pharmacy, Satna (M.P.) -INDIA
  • Neeraj Upmanyu RKDF College of Pharmacy, Bhopal (M.P.) -INDIA
  • S.D. Tonpay S.D. Tonpay, G.R. Medical College, Gwalior (M.P.) -INDIA

Keywords:

ophthalmic preparation, indomethacin salt, aqueous eye drops, poor water soluble drugs

Abstract

Product development of ophthalmic preparations has received considerable attention in the last few years. With the increasing emphasis on their sterility, some of the differences between them and parenteral preparations are becoming less evident. Both classes of preparations employ similar added substances and manufacturing procedures. The successful formulation of poorly water-soluble drugs is one of the major problems in pharmaceutical manufacturing. Poorly water-soluble drugs, such as indomethacin, may show low and erratic oral bioavailability due to poor dissolution of the drug in the fluids of the gastrointestinal tract. Indomethacin is a water insoluble drug, so problems of formulating an aqueous eye-drop are well known. Moreover, unstability of Indomethacin aqueous preparations is also a great challenge. In this research work, considering pharmacological importance of drug Indomethacin, we tried to overcome the problem of poor water solubility by making a salt of it and thus formulating an aqueous ophthalmic preparation.

References

JK Pandit, D Bharathi, A Srinatha, DN

Ridhurkar, S Singh, Long acting

ophthalmic formulation of indomethacin:

Evaluation of alginate gel systems, Indian

Journal of Pharmaceutical Sciences, (2007),

(1), 37-40.

Carter, S.J.; Cooper & Gunn’s Dispensing

for Pharmaceutical Students, Ophthalmic

Products, 634-653.

Gaynes Bruce, Fiscella Richard, Topical

nonsteroidal anti-inflammatory drugs for

ophthalmic use: A safety review, Drug

safety, (2002), 25 (4), 233-250.

Fronza, G.; Male A.; Redenti, E.; Ventura,

P.; 1H NMR and Molecular Modeling

Study on the inclusion complex .beta. –

Cyclodextrine-Indomethacin, Journal of

Organic Chemistry (1996), 61(3), 909-14.

El-Shattawy, Hamed; Kassem, Alaa; Omar,

Sanaa; Sami, Ahmed; Yassin, Alaa-El-Din,

Preparation and evaluation of directly–

compressed indomethacin, indomethacin

sodium and indomethacin meglumine

tablets, Drug Development and Industrial

Pharmacy (1994), 20(5), 901-9.

Curry, Stephen H.; Brown, Edgar A.; Kuck,

Hilken; Cassin, Sidney; Preparation and

stability of indomethacin solutions,

Canadian Journal of Physiology and

Pharmacology (1982), 60(7), 988-92.

Pharmacopoeia of India, 1985, Vol.-I, 3rd

Edition, Government of India, Ministry of

Health and Family Walefare: 253.

Carstensen, J.T.; Drug Stability-Principles

and Practices, Marcel Dekker Inc., II Edi.,

Vol. 68, 285.

Downloads

Published

2011-03-31

How to Cite

Sunisha Kulkarni, Surya Prakash Gupta, Neeraj Upmanyu, & S.D. Tonpay. (2011). Solubility Enhancement of Water Insoluble Drug for Ophthalmic Formulation. International Journal of Drug Delivery, 3(1), 141–148. Retrieved from https://ijdd.arjournals.org/index.php/ijdd/article/view/65

Issue

Section

Original Research Articles